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License 4.0 (CC BY-NC).Intraoperative detection of blood vessels with an
imaging needle during neurosurgery in humans
Hari Ramakonar1,2, Bryden C. Quirk3,4,5, Rodney W. Kirk3,4,5, Jiawen Li3,4,5, Angela Jacques1,6,
Christopher R. P. Lind1,2, Robert A. McLaughlin3,4,5*
Intracranial hemorrhage can be a devastating complication associated with needle biopsies of the brain. Hemorrhage
can occur to vessels located adjacent to the biopsy needle as tissue is aspirated into the needle and removed. No
intraoperative technology exists to reliably identify blood vessels that are at risk of damage. To address this problem,
we developed an “imaging needle” that can visualize nearby blood vessels in real time. The imaging needle contains a
miniaturized optical coherence tomography probe that allows differentiation of blood flow and tissue. In 11 patients,
we were able to intraoperatively detect blood vessels (diameter, >500 mm)with a sensitivity of 91.2% and a specificity
of 97.7%. This is the first reported use of an optical coherence tomography needle probe in humanbrain in vivo. These
results suggest that imaging needles may serve as a valuable tool in a range of neurosurgical needle interventions.INTRODUCTION
Stereotactic brain biopsies are a minimally invasive procedure used to
obtain samples of intracranial tissue for diagnostic purposes, most
commonly related to brain tumors. Approximately 80,000 new cases
of primary brain tumor are diagnosed, and 14,000 brain biopsies are
performed each year in theUnited States (1, 2). Hemorrhage is themost
frequent and devastating complication associated with this procedure.
Perioperative hemorrhage is associated with rates of transient and per-
manentmorbidity of 1.7 to 8.5% and 1.4 to 4.8%, respectively, andmor-
tality rates of 0.6 to 2.8% (3–7).
The standard clinical practice is to identify blood vessels at risk of
injury on preoperative imaging, using either contrast-enhanced mag-
netic resonance imaging (MRI) or x-ray computed tomography. Frame-
less stereotactic navigation techniques, guided by preoperative imaging,
are then used to direct the biopsy needle trajectory to sample the target
lesion, while avoiding vasculature or eloquent brain tissue (8).
However, these standard techniques do not eliminate the risk of
hemorrhage, as they are limited by their spatial resolution in the detec-
tion of smaller vessels and do not account for errors in stereotactic
precision. Precision in stereotactic navigation is dependent on the qual-
ity of the preoperative imaging, accuracy of the image-to-patient regis-
tration, mechanical error of the trajectory guide, and accuracy of
intraoperative probe tracking (9, 10). Preoperative imaging can be im-
peded by patient motion, limited spatial resolution, and a range of
imaging artifacts. Image-to-patient registration can be affected by ge-
ometrical lesional changes, such as rapidly evolving neoplasms, cere-
brospinal fluid loss, cerebral edema, or cystic decompression (9, 10).
These factors can result in brain shift. While less notable during burr
hole–based procedures than in open surgery, Ivan et al. (11) quantified
the shift as up to 10.1mm. In addition, accuracy of intraoperative probe
tracking can suffer stereotactic error or line-of-sight deficiencies (12–14).Either one or a combination of these factors can contribute to increased
hemorrhage risk.
Several techniques have been developed to perform neurosurgical
procedures with improved guidance. Intraoperative MRI allows for
real-time updates during surgery; however, this technique is often im-
practical due to workflow interruptions and can be very expensive
(15–17). Intraoperative ultrasound has been used widely throughout
neurosurgery; however, it is impractical with regard to its use in
stereotactic brain biopsies due to its large probe size and poor spatial
resolution for detection of vessels smaller than 2 mm in diameter
(18–20). Indocyanine green is used in neurosurgery for blood vessel
visualization but requires a direct line of sight to the vessel (21).
Optical techniques, including laser speckle imaging (22–24), laser
Doppler (25), and diffuse correlation spectroscopy (26), have been
used to visualize superficial blood flow in an open surgery setting. A
forward-facing laser Doppler flowmetry probe has been integrated
into a stereotactic system for guidance of deep brain stimulation elec-
trodes and demonstrated in human surgery (27–29). This system has
been adapted for use during brain biopsies, although it has not been
integrated with a brain biopsy needle (30). Instead, the optical probe
was inserted along the planned needle trajectory and then fully
retracted, and the biopsy needle was subsequently inserted. Prelimi-
nary work has also explored the integration of a multifiber optical
spectroscopy system into a brain biopsy needle, but this work has
not progressed to assessment in humans (31).
Here, we explore the use of optical coherence tomography (OCT)
to intraoperatively detect vessels at risk of intracranial hemorrhage.
OCT is an optical imaging technique commonly used in ophthalmol-
ogy (32) and cardiology (33, 34). OCT is label free, requiring no exog-
enous contrast agent, and instead is dependent on the endogenous
optical scatterers in the tissue. Tissue is illuminated using near-infrared
light, and the backscattered optical signal is reconstructed into a struc-
tural image of the tissue, typically at a spatial resolution of 5 to 20 mm,
although resolutions as small as 1 to 2 mmhave been achieved (35, 36).
OCT provides depth-resolved imaging, where the backscattered sig-
nal from different depths is extracted using low-coherence interfer-
ometry (37) by optically interfering the backscattered light beam with
a reference light beam reflected along a path of known optical path
length. Using terminology adapted from the field of ultrasound imag-
ing, an A-scan (amplitude scan) refers to a single OCT acquisition and
provides a one-dimensional (1D) measurement of optical backscatter1 of 10
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acquired to form a 2D image of the tissue, referred to as a B-scan.
A limitation of OCT is its image penetration depth. This is typically
restricted to 1 to 1.5 mm in turbid tissue by the confounding effects of
optical scattering and absorption (38–40). However, brain biopsy
needles are inserted to a depth of several centimeters, well beyond the
range of OCT. This has necessitated the development of miniaturized
fiber-optic probes, which may be incorporated into the hypodermic
needle to provide guidance near the distal tip of the needle as it is
inserted at depth (41). Previous studies have demonstrated the use of
these imaging needles in a range of tissues, including breast (42–44),
lung (45, 46), and brain (47, 48).While the design of these probes is well
established, their use in human studies is very limited, with most work
restricted to animal or ex vivo human tissue, and no previous studies
have demonstrated their use for in vivo human brain.
We have developed a miniaturized fiber-optic probe using OCT for
the detection of cerebral blood vessels. This probe was integrated into a
standard commercial neurosurgical stereotactic biopsy needle and
tested intraoperatively in 11 live human patients undergoing crani-
otomy. The probe detected surface blood vessels (diameter, >500 mm)
with a sensitivity of 91.2% and a specificity of 97.7% andwas also able to
successfully detect deep blood vessels. To the best of our knowledge, this
is the first successful in vivo human trial to examine detection of blood
vessels in the brain using OCT.RESULTS
A brain biopsy imaging needle
We developed an optically guided biopsy needle capable of OCT imag-
ing (Fig. 1), integrated into a standard clinical brain biopsy needle
(Passive Biopsy Needle Kit, Medtronic), with the goal of identifying
the presence of blood vessels before biopsy tissue cutting. As the needle
was inserted, the system displayed the OCT image (providing a struc-
tural view of the tissue microstructure) overlaid with the local measure-
ments of flow, providing near real-time feedback of vessel detection to
the surgeon. Blood vessels were automatically detected through the use
of an algorithm to analyze the rate of speckle decorrelation in the OCT
image. Details of the needle design and blood vessel detection algorithm
are given in Materials and Methods.
We devised two clinical protocols with their respective aims:
(1) Superficial vessel protocol: to evaluate the ability of the probe
to detect cerebral vasculature against a gold standard.Ramakonar et al., Sci. Adv. 2018;4 : eaav4992 19 December 2018(2) Deep vessel protocol: to demonstrate that the probe was able
to detect cerebral blood vessels at depth and illustrate its integra-
tion into clinical workflow.
Superficial vessel protocol
To quantify the ability of the probe to detect cerebral vasculature, it
was important to devise experiments where a gold standard is availa-
ble, including vessels not reliably visible on standard preoperative im-
aging. To achieve this, we compared the OCT measurements of
superficial blood vessels on the brain surface (after craniotomy)
against a gold standard of intraoperative photographs acquired during
OCT imaging. This involved 11 patients undergoing craniotomy for
indications including tumor, dermoid, and arteriovenous mal-
formation excision. Patient demographics were seven (63.3%) females
and four (36.4%) males. Mean (SD) age was 62.2 (15.3) years. We
acquired 160 data points across 11 patients (44 controls, 55 arteries,
and 61 veins).
For each patient, craniotomy and durotomy were performed, and
the imaging needle, fitted within the outer cannula of a standard brain
biopsy needle, was placed over a range of surface blood vessels within
the operative field. Two OCT measurements were acquired for each
blood vessel, and a photograph was concurrently acquired with a ster-
ile scale bar in the field of view while the imaging needle was
positioned on the vessel. This enabled easy identification of the mea-
sured blood vessel during analysis. During surgery, each vessel was
analyzed by an experienced neurosurgeon (H.R. or C.R.P.L.) and
classified as either artery or vein, based onmacroscopicmorphological
features, including vessel wall appearance, pulsatility, compressibility,
and color, and by tracing it back to its parent vessel. The classification
was subsequently confirmed in postoperative analysis of the photo-
graph. Postoperatively, the blood vessel diameter was measured from
the photograph using imaging software [ImageJ (49)]. Control mea-
surements with no visible vasculature were obtained fromdura, arach-
noid, and cerebral cortical surfaces.
We performed differentiation of blood vessel fromnonvascular con-
trol tissue using a fully automated analysis algorithm that compared the
averageOCT speckle decorrelation across the two acquisitions against a
threshold value. We used the same threshold across all datasets. Scans
where the average speckle decorrelation was above the threshold were
categorized as containing vessels. This was then tabulated against the
photographic gold standard to assess accuracy of the algorithm. There
was a significant difference between the median of the average speckleFig. 1. Imaging needle design. (A) Schematic of the distal end of the fiber-optic probe. (B) Schematic of the distal end of the imaging needle, showing the outer
needle, inner stylet, and fiber-optic probe. (C) Photo showing the imaging needle inserted into a human brain during surgery (photo credit: The Audio Visual Production
Unit, Sir Charles Gairdner Hospital).2 of 10
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scans (P < 0.001).
We scanned a wide range of vessel diameter sizes from 110 mm to
1.2 mm, with a median size of 500 mm. We performed analysis on
two subsets of the data: larger vessels and all vessels. There is no
accepted threshold vessel diameter that defines a clinically signifi-
cant vessel, and other factors such as location and territorial supply
contribute to clinical importance. We arbitrarily chose a cutoff, such
that vessels with a diameter greater than themedian of 500 mmwould
be denoted as the larger vessels, allowing us to exclude extremely
small vessels that are less likely to be clinically relevant. This resulted
in 101 data points across the 11 patients (44 controls, 14 arteries, and
43 veins with a diameter of >500 mm). Sensitivity, specificity, positive
predictive value, and negative predictive value for both analyses
(larger vessels and all vessels) are summarized in Table 1.
By varying the threshold value of average speckle decorrelation that
is used to differentiate vessels from control tissue, optimal sensitivity
and specificity for blood vesselswith a diameter of greater than 500 mm
were found to be 91.2 and 97.7%, respectively. A receiver operating
characteristic (ROC) curve for the threshold values was calculated
(Fig. 2), giving an area under the curve (AUC) [95% confidence inter-
val (CI)] of 0.975 with P < 0.0001. No significant difference was ob-
served in the detection frequency of arteries and veins (P = 0.319).
When including all vessels (down to the minimum diameter of
110 mm), we chose a lower threshold value of average speckle decorrela-
tion to achieve an optimal sensitivity and specificity of 86.2 and 86.4%,
respectively. When analyzing all vessels, the ROC had an AUC (95% CI)
of 0.945 with P < 0.0001.We partially attribute this decrease in sensitivity
and specificity to the reduced speckle decorrelation present in extremely
small vessels. However, we also note that accurately rolling the imaging
needle across extremely small vessels in an in vivo setting can be chal-
lenging, and some vessels may not have been detected because of exper-
imental error in positioning of the needle. As with the larger vessels, there
was no significant difference between detection frequency of arteries and
veins (P = 0.591).
Figure 3A shows the exposed cortical surface of a patient under-
going tumor resection following craniotomy and durotomy. Surface
blood vessels are evident on the cortical surface as the imaging needle
is being rolled across a vessel to acquire a measurement. The cor-
responding OCT structural (Fig. 3B) and speckle decorrelation images
(Fig. 3C) are shown. The left half of these scans was acquired over the
vessel, and the right half was acquired over adjacent nonvascular tissue.
Note the difference in the texture of the OCT, originating from rapid
decorrelation of the intensity values where there is blood flow. The
measured speckle decorrelation is color coded in Fig. 3C, with areas
of high speckle decorrelation color coded in white and yellow, graduat-
ing to dark red for low speckle decorrelation. The speckle decorrelation
color bars in Figs. 3 to 8 are all plottedwith the same scale. However, the
units are arbitrary units rather than absolute flow speed, as it was not
possible to sufficiently correct for variations in the speed with whichRamakonar et al., Sci. Adv. 2018;4 : eaav4992 19 December 2018the neurosurgeon manually moved the needle. The size of the scale
bars in Figs. 3 to 8 is 500 mm, assuming a refractive index of 1.36 for
brain tissue (50).
Figure 4 shows representative OCT scans of vessels and the
corresponding speckle decorrelation images. Note the thick vessel wall
visible in the arteries shown in Fig. 4 (A and B). As expected, the walls
of the veins shown in Fig. 4 (C and D) are much thinner. A pulsatile
variation is visible in the speckle decorrelation of the artery of Fig. 4B,
corresponding closely to the patient’s heart rate of 61 bpm as mea-
sured intraoperatively with electrocardiography (Datex-Ohmeda, GE
Healthcare). The pulse rate was estimated from the OCT by manually
measuring the average number of A-scans per pulse, scaled by the
A-scan acquisition rate of 23 kHz. Pulsatile flow was observed in
some arteries but was not present in any veins.
Representative examples of control scans are presented in Fig. 5,
showing both arachnoid tissue (Fig. 5, A and B) and cortical tissue
(Fig. 5, C and D). The pia mater could be delineated in some cortical
scans. Small, focal areas of high speckle decorrelation are visible in the
control scans, typically corresponding to the edges of structures or noise
in the measurements. However, the average speckle decorrelation value
across the entire scan was significantly lower than that for scans of
vessels (P < 0.001).
Deep vessel protocol
For the final three patients enrolled in the study, we demonstrated
deep blood vessel detection with the imaging needle. Our aim was
to ascertain whether the probe could detect vessels at depth, similar
to its proposed clinical application.
All three patients had grade IV astrocytomas. One deep vessel per
patient was selected on preoperative MRI immediately adjacent to
the tumor. The needle trajectory chosen was the most direct to the
target vessel, while remaining within the region scheduled for subse-
quent resection after imaging. A single burr hole was made, and theTable 1. Results of the superficial vessel protocol.Sensitivity Specificity Positive predictive value Negative predictive valueVessels > 500 mm (57 vessels and 44 controls) 91.2% 97.7% 98.1% 89.6%All vessels (116 vessels and 44 controls) 86.2% 86.4% 94.3% 70.4%Fig. 2. ROC curves for vessel detection. Blue indicates analysis of larger vessels
(diameter, >500 mm). Black denotes analysis of all vessels (diameter, 110 mmto1.2mm).3 of 10
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biopsy needle, was targeted to the vessel using stereotactic navigation
(StealthStation, Medtronic). Once at target depth, the needle was ro-
tated to ascertain the presence of the target vessel, and the OCT
speckle decorrelation pattern was observed intraoperatively. The
needle was then withdrawn, and the standard procedure for craniot-
omy and resection of tumor proceeded as planned. The presence of
the vessel was detected with an automated image processingRamakonar et al., Sci. Adv. 2018;4 : eaav4992 19 December 2018algorithm described inMaterials andMethods. For all three patients,
the imaging needle was able to detect blood vessels at depth.
Figure 6 demonstrates the case of a 69-year-old male undergoing
craniotomy and resection of a left parietal high-grade glioma. The 3D
volumetric rendering of theMRI illustrates the needle trajectory, with a
small green rectangle delineating the 8-mm trajectory from the surface
of the cortex to the vessel, over which the OCT scan was acquired. The
total insertion distance from the outer surface of the skull was 21.9 mm.
The inset shows the OCT scan overlaid with the speckle decorrelation
image. A vessel, previously identified on the MRI scan (diameter on
MRI, 1.7mm), is identified at the deepest part of the insertion as an area
of high speckle decorrelation, overlaid in red.
Figure 7 demonstrates a second deep tissue insertion for a 58-year-
old female undergoing right frontal craniotomy. The inset shows
overlaid OCT and speckle decorrelation scans over a trajectory dis-
tance of 7.5 mm, terminating at the vessel. The total insertion distance
was 25.3mm. The targeted vessel (diameter onMRI, 1.7 mm) appears
as a region of high speckle decorrelation. The OCT shows that the
needle trajectory passed through a fluid-filled void, indicating a sulcus
and appearing as an area of low backscatter in the OCT.We infer that
the void is likely to be fluid filled because an air-filled void would show
high optical backscatter (largeOCT signal) at the interfacewhere there
is a large refractive index change between air and tissue, but no such
interface is evident. The needle trajectory subsequently passed
through a superficial region of cortical tissue (labeled solid tissue) with
high backscatter.
Our final deep insertion was acquired on a 64-year-old male under-
going left temporal craniotomy and resection for glioblastoma multi-
forme. A vessel adjacent to the tumor was targeted (diameter on
MRI, 1.6 mm). The OCT scan was acquired over the deepest 11.5 mm
of the insertion, extending from the surface of the cortex. The total
insertion distance was 27.2 mm. The vessel is shown detected in the
OCT scan at the deepest part of the scan (red rectangle on the far left
in theOCT inset of Fig. 8). Note that two smaller,more superficial vessels
were also identified in the OCT data and are both delineated in Fig. 8.
These vessels are below the 1-mm resolution of the MRI scan and wereFig. 3. Superficial vessel protocol. (A) Photo of an imaging needle being rolled over a vessel (vessel diameter, 650 mm). The imaging window (not visible) is 0.5 mm
from the end of the needle and is facing toward the tissue. A sterile scale bar is present and allows subsequent estimation of vessel diameter. (B) OCT B-scan consisting
of A-scans acquired as the needle is manually rolled across the tissue. Tissue surface corresponds to the top of the OCT image, with depth increasing as we move down
the image. (C) Speckle decorrelation image calculated from the OCT scan. Areas of high decorrelation are shown as white, and areas of low decorrelation are shown as
dark red. These values are averaged and compared against a threshold to detect the presence of a vessel in the scan. Vertical scale bars, 500 mm (photo credit: The
Audio Visual Production Unit, Sir Charles Gairdner Hospital).Fig. 4. Blood vessel scans. In each pair of images, the OCT scan is shown on top
and the corresponding speckle decorrelation image is shown below. (A and B)
Arteries (vessel diameter, 720 and 260 mm). (C and D) Veins (vessel diameter,
1000 and 800 mm). Vertical scale bar, 500 mm.4 of 10
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the targets for these three individuals are given in figs. S1 to S3.DISCUSSION
We have demonstrated that OCT speckle decorrelation is capable of
accurately identifying cerebral blood vessels in live humanpatients. Fur-
thermore, we have shown that this can be donewithminimal disruption
to current clinical workflow. Only minor changes in surgical technique
are required, as theOCT probe is readily interchangeable with the inner
stylet of a standard brain biopsy needle.
In clinical practice, the imaging needle has the potential tominimize
hemorrhage by avoiding blood vessel sampling through the tissue-
cutting window. By minimizing hemorrhage, the complication profile
of the procedure is minimized. Furthermore, diagnostic yield could be
further improved by facilitating safer acquisition of a greater number of
tissue samples without increasing hemorrhagic risk (51). This, in turn,
would contribute to improving cost-effectiveness by reducing the num-
ber of repeat procedures that are required.
Adverse clinical outcomes associated with stereotactic biopsies and
hemorrhagic complications are primarily related to the vascular terri-
tory supplied by that blood vessel, as well as any potential mass effect
that intracranial hemorrhagemay cause (52, 53). There are nopublished
data reflecting what vessel diameter may be clinically relevant with re-
gard to hemorrhagic complications. As the brain is highly vascular, it is
almost inevitable that very small vessels may be damaged during the
insertion of a stereotactic needle. We were able to reliably visualize
blood vessels greater than 500 mm in diameter. We note that some
speckle decorrelation algorithms provide an estimate of blood flow
speed (54) and, combinedwith an estimate of vessel diameter, this could
provide an indication of blood flow volume that may lead to more reli-
able indication of clinical significance.Ramakonar et al., Sci. Adv. 2018;4 : eaav4992 19 December 2018Optical imaging techniques are well suited for use in an intra-
operative setting due to the lack of ionizing radiation, the real-time na-
ture of the images, and the ability to miniaturize the imaging hardware.
Previous work has explored the use of laser Doppler imaging (25) and
variants of laser speckle imaging (22–24, 55) to monitor cerebral blood
flow without the need for an exogenous contrast agent. Alternative
approaches have involved video imaging of a fluorescent contrast agent,
indocyanine green, to provide an indication of perfusion (21, 56). How-
ever, all of these optical approaches have been restricted to assessing
superficial flow in open surgery because of the lack of penetration of
the light in turbid tissue. Optical techniques working in the diffuse re-
gime, both with (57) and without (26) contrast agent, achieve a greater
penetration depth but with a very poor spatial resolution that is unable
to identify individual vessels at risk during an intervention. Our ap-
proach of miniaturizing the imaging probe and encasing it within the
needle offers an alternative solution to the issue of limited penetration
depth in high-resolution optical techniques, placing the imaging probe
at the point of tissue sampling. A similar approach has been demon-
strated using a miniaturized, forward-facing laser Doppler flowmetry
probe, both in deep brain stimulation (27–29) and brain biopsy inter-
ventions (30). However, our design is the first to combine the optical
probe into the biopsy needle, integrating it into the clinical workflow
and avoiding the need for additional needle insertions.
The device presented here performs imaging through the tissue-
cutting window. However, intracranial hemorrhage may also occur if
the needle penetrates a vessel during insertion. While there are no sta-
tistics comparing the incidence of hemorrhage from tissue cutting ver-
sus needle insertion, we note that hemorrhage rates in interventions
where no tissue cutting is performed are substantially reduced, suggest-
ing that many bleeds occur during tissue cutting. For example, in deep
brain stimulation, rates of symptomatic hemorrhage vary from 0.5 to
2.1% (58, 59), compared with 1.7 to 8.5% for biopsy (3–7). There is also
the potential to incorporate a forward-facing OCT probe within the
biopsy needle to reduce risk during needle insertion. These designs have
already been demonstrated for non-neurosurgical applications (44),
and our team has demonstrated a forward-facing optical design similar
to that used in this current paper (60). We note that the diameter of theFig. 6. Deep vessel protocol. 3D volume rendered MRI scan showing needle
trajectory in a 69-year-old male patient. The small green rectangle indicates the
region in which OCT scanning was performed. The inset shows the overlaid OCT
(gray) and speckle decorrelation (color) images, with the automatically delineated
vessel indicated by a red rectangle.Fig. 5. Control scans. In each pair of images, the OCT scan is shown on top and the
corresponding speckle decorrelation image is shown below. (A and B) Arachnoid
tissue. (C and D) Cortical tissue. Vertical scale bars, 500 mm.5 of 10
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probe is 900 mmindiameter due to a protectiveHytrel jacket around the
fiber. This small size allows for both a forward-facing probe and a side-
facing probe to be incorporated into the stylet of a standard brain biopsy
needle, to provide imaging to mitigate hemorrhage arising from both
needle insertion and tissue cutting.
These small imaging probes have the potential to be integrated into
other areas of probe-based neurosurgery, such as electrode placement in
deep brain stimulation, where hemorrhage may occur by direct trauma
during needle insertion. This could potentially increase utilization of this
procedure across additional indications by improving the risk profile.
Previous studies have also demonstrated the use of OCT in deep brain
animal models for precise anatomical localization, with the potential to
aid electrode placement (48). In addition to tissue biopsy applications,
theseminiaturized imaging probesmay enable better targeting of ther-
apeutic injections, and earlier work by our group has demonstrated a
22-gauge needle (outer diameter, 720 mm), integrating a fiber-optic
OCT probe with a second channel for injection of a fluid (61).
Other groups have developed small form factor probes for neuro-
surgery, integrating different optical modalities (30, 62–66), including
Raman spectroscopy and 5-aminolevulinic acid/protoporphyrin IX
(5-ALA/PpIX) imaging, to differentiate healthy from pathological
tissue. It would be feasible to integrate our blood vessel detection ca-
pabilities with these other modalities, and a combined OCT and flu-
orescence probe has already been proposed by our group (67). This
would allow the imaging needle to have multimodal capabilities, with
the potential to optimize biopsy sampling by using fluorescence or the
Raman spectrum to identify when malignant tissue is adjacent to the
tissue-cutting window, while using OCT to identify blood vessels at
risk of hemorrhage.
OCT speckle decorrelation detection of cerebral blood vessels holds
great promise to reduce hemorrhagic risk from stereotactic brain biopsy.
Limitations of the technology do, however, exist, predominantly the
small penetration depth of approximately 1 to 1.5 mm in optically scat-
tering tissue (38–40). This depth is not limited by the power of the im-
aging light but, instead, by the confounding effects ofmultiple scattering.
However, even with this limited imaging depth, the device still has the
potential to reduce the risk of hemorrhage. In conclusion, this workRamakonar et al., Sci. Adv. 2018;4 : eaav4992 19 December 2018presents a technique for real-time blood vessel detection integratingwith
current clinical workflow with >90% sensitivity and specificity and sets
the stage for further clinical trials to evaluate its safety and efficacy.MATERIALS AND METHODS
Study design
The objective of this study was to assess the capability of OCT to detect
intracranial blood vessels in humans. We hypothesized that imaging
needles can differentiate vascular from nonvascular tissue in a neuro-
surgical setting. A customized fiber-optic probe integrated into a com-
mercial stereotactic biopsy needle was used in adult neurosurgical
patients (n = 11) at Sir Charles Gairdner Hospital, Western Australia.
The indications for craniotomy included tumor, arteriovenous mal-
formation, and intracranial dermoid resection. Exclusion criteria in-
cluded people under the age of 18, people unable to give informed
consent, non–English-speaking people, and patients with a bleeding
disorder. Informed consent was obtained from each patient according
to the Sir Charles Gairdner Group Human Research Ethics Committee
(HREC no. 2014-062). Patients were evaluated preoperatively with
complete clinical examination and imaging workup including a
stereotactic MRI brain scan. Data consisted of n = 160 measurements,
including 44 control sites, 55 arteries, and 61 veins. When restricted to
vessels with a diameter of >500 mm and controls, there were n = 101
measurements, including 44 control sites, 14 arteries, and 43 veins.
Handheld imaging needle
The needle comprises a standard outer metal sheath (Passive Biopsy
Needle Kit, Medtronic, USA), encasing a custom-built imaging stylet.
The stylet incorporates a side-viewing, fiber-optic probe connected to
a spectral-domainOCT system (Telesto II, Thorlabs, USA). In clinical
practice, the imaging stylet would be removed and replaced with the
standard hollow stylet for biopsy tissue cutting once the needle was
safely positioned at the point of biopsy. Use of the standard outer
metal sheath (which includes fiducials for optical tracking) enabled
easy calibration of the imaging probe with the stereotactic guidance
system (StealthStation, Medtronic, USA) and allowed us to recordFig. 7. Deep vessel protocol. 3D volume rendered MRI scan showing needle
trajectory in a 58-year-old female patient. The small green rectangle indicates
the region in which OCT scanning was performed. The inset shows the overlaid
OCT (gray) and speckle decorrelation (color) images, with the automatically delin-
eated vessel indicated by a red rectangle.Fig. 8. Deep vessel protocol. 3D volume rendered MRI scan showing needle
trajectory in a 64-year-old male patient. The small green rectangle indicates the
region in which OCT scanning was performed. The inset shows the overlaid OCT
(gray) and speckle decorrelation (color) images, with multiple automatically delin-
eated vessels indicated by red rectangles.6 of 10
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operative MRI.
The imaging probe comprised a 3-m length of single-mode optical
fiber (SMF-28-J9, Thorlabs, USA). At the distal end of the fiber, we fab-
ricated focusing optics as described in (41). Briefly, a 350-mm length of
no-core fiber (Success Prime Corporation, Taiwan) and 150 mm of
graded-index (GRIN) fiber (DrakaElite, The Netherlands) were spliced
to the single-mode fiber (SMF) to produce a weakly focused optical
beam.Thiswas terminatedwith a section of no-core fiber, angle polished
at 52°, that redirected the light beam approximately perpendicular to the
fiber using total internal reflection (TIR) at the fiber-air interface. The
optical assembly was encased within a glass capillary and rigidly affixed
with optical adhesive (NOA86H, Norland, USA) within a metal stylet
(outer diameter, 2 mm; Minitubes, France) that had the same diameter
as the standardMedtronic stylet (Passive Biopsy Needle Kit, Medtronic,
USA). The glass capillary was necessary to maintain the TIR fiber-air
interface once the probe was embedded in optical adhesive. The probe
was positioned so that the light beamwas emitted through a small im-
aging window (diameter, 500 mm), which had been drilled in the wall
of themetal stylet. This was then oriented to perform imaging through
the 5-mm (length) tissue-cutting window in the outer metal sheath of
the biopsy needle.
Before use, the imaging probe was cleaned in amedical-grade wash-
ing machine (Steelco SpA, Italy), dried, and double bagged in Tyvek
(DuPont, Virginia, USA), a high-density polyethylene. It was then ster-
ilized using STERRAD (Advanced Sterilization Products, USA), a low-
temperature, hydrogen peroxide gas plasma technique. Each probe was
discarded after one surgery.
OCT imaging
The imaging probe was interfaced proximally to a commercial spectral-
domain OCT system (Telesto II, Thorlabs, USA) with a central
wavelength of 1300 nm and an axial resolution of 5.5 mm (in air). Dur-
ing each neurosurgical procedure, OCT A-scan measurements were
acquired at a rate of 23 kHz as the needle was manually moved over
or inserted through the tissue.
Automated vessel detection
In coherent imaging techniques, such as OCT, speckle arises because of
the simultaneous backscatter of light frommultiple subcellular compo-
nents within a single imaging resolution element. The combined reflec-
tions may interfere constructively or destructively, giving rise to bright
and dark speckles (68). As the tissue moves, such as movement of red
blood cells in a vessel, the collection of subcellular components changes,
and this alters the interferedOCT signal. Blood vessels, containingmov-
ing particles, appear as a region of rapid speckle decorrelation, and this
has been used to identify vasculature (54, 69–71). The rate of change in
the OCT signal is related to the speed of movement, allowing differ-
entiation of the rapid movement of red blood cells from the compara-
tively slowmovement arising from insertion of the needle. Note that the
degree of speckle decorrelation is a function of the quantity of moving
red blood cells within the imaging light beam, not the vessel size. Thus, a
dense collection of small vessels will give comparable speckle decorrela-
tion to a single larger vessel with similar total flow.
Assessment of the rate of speckle decorrelation is complicated by a
number of probe- and tissue-related factors, including the width of the
imaging light beam, the signal-to-noise ratio of optical backscattering,
and the presence ofmultiple scattering in theOCT signal. To correct for
these confounding factors, we devised an algorithm that computedRamakonar et al., Sci. Adv. 2018;4 : eaav4992 19 December 2018speckle decorrelation as a function of depth within the tissue and nor-
malized against a control measurement taken over stationary, non-
vascular brain tissue. A single control measurement was used for
analysis of all patient scans.
We defined a 2D coordinate system, where x indexes the sequence
of A-scans and z is oriented in the direction of the light beam (i.e.,
along the A-scan), such that the x-z plane defines an OCT B-scan.
Given a subset of closely spaced A-scans as input data (a sequence of
500 A-scans was empirically chosen in this application), we calculated
the square root of the normalized sum of squared intensity differences
as a function of distance dx between the A-scans. This may be written
as the square root of the expected value of the sumof squared intensity
differences
f ðdxÞ ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
E½ðIðx; zÞ  Iðx þ dx; zÞÞ2
q
ð1Þ
where E[] denotes the expected value of a function, I(x, z) is the OCT
intensity at (x, z), x is taken over all A-scans in the subset, and z is
taken over a small, fixed window size within which the OCT signal
does not notably attenuate. For small dx values, f(dx) will be small with
intensities highly correlated. The value of f(dx) will increase with in-
creasing dx until it reaches a saturation value where there is negligible
correlation between corresponding values in a pair of distant A-scans.
We normalized these values to the range [0…1] by dividing them by
the median value of f(dx) for dx greater than any anticipated correlation
in the A-scan data. This gives d(dx), a normalized measure of speckle
decorrelation between pairs of A-scans that are a distance dx apart
dðdxÞ ¼ f ðdxÞ
medianf f ðdx0Þ : n1 < dx0 < n2g ð2Þ
where n1 and n2 are lower and upper bounds of a range of values of dx
over which A-scans are highly decorrelated (100 and 400, respectively, in
our application). Calculating d(dx) over a range of values for dx (1…40 in
our application), we obtained a decorrelation curve that quantifies the
increase in decorrelation between increasingly distant A-scans.
We acquired a control scan by rolling the imaging needle over a non-
vascular region of exposed cortical tissue three times, providing a data-
set of approximately 600,000 A-scans from which we calculated the
decorrelation curve for control tissue. This dataset was used for evalu-
ation of all otherOCT scans in the study. As speckle decorrelation varies
with imaging depth due to factors such as multiple scattering, we
calculated a sequence of curves at increasing depths below the tissue
surface. Analysis of OCT test data was performed against a curve of
the appropriate depth taken from this control scan.
The rate at which the curve increases from 0 (highly correlated in-
tensity values) to 1 (decorrelated intensity values) will increase in the
presence of blood flow, as closely positioned A-scans will be less
correlated due to movement of the red blood cells during acquisition
of the A-scans. To detect the presence of a blood vessel in a new
OCT dataset, the decorrelation curves were first calculated for each sub-
set of data and at each depth. Each curvewas then linearly scaled in the
x direction to best fit the control curve (using theEuclideanL2-norm). Let
us denote the scaling factor as s. The amount of scaling s quantifies the
speckle decorrelation compared to stationary, control tissue. Stationary
tissue required little scaling from the control scan (s≈ 1), while areas
of rapid blood flow generated a decorrelation curve that is scaled in7 of 10
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tected when the average scaling factor (taken across all subsets in the
dataset) was above an empirically selected threshold value.
The sensitivity and specificity values shown inTable 1 are for specific
threshold values. A different threshold value was chosen when the anal-
ysis was restricted to large vessels (diameter, >500 mm) or all vessels.
However, within each analysis, the same threshold value was used
across all datasets and across all individuals. ROC curves were obtained
by calculating sensitivity and specificity as the threshold value was var-
ied. In the speckle decorrelation images shown in Figs. 3 to 8, we con-
structed an imagewhere large values of swere graphically represented as
bright pixels (white and yellow), while small values of swere represented
by dark pixels (dark red).
For the three deep vessel insertions, the blood vessels were detected
with an automated algorithm that used a simple pipeline of image pro-
cessing techniques. The algorithm first calculated the mean speckle de-
correlation (specified earlier by the scaling factor s) within each A-scan
and smoothed these values between adjacent A-scans with a median
filter. Smoothed flow values above a threshold value were marked as
indicating vessels. Vessels smaller than a predefined number of A-scans
were discarded. In all three acquisitions, the target vessel was success-
fully delineated.
Preoperative MRI protocol for deep insertion acquisitions
For the three deep vessel insertion subjects, preoperativeMRI scanswith
gadolinium contrast agent were acquired to identify target vessels and
plan the insertion trajectory of the imaging needle. For subjects 1 and 3
(Figs. 6 and 8), scans were acquired with a Siemens 1.5T Aera using the
following protocol: T1-weighted, gradient-eco sequence (MP RAGE),
repetition time (TR) = 1910 ms, echo time (TE) = 3.14 ms, inversion
time (TI) = 1100 ms, flip angle = 15°, slice thickness = 1 mm, and pixel
size = 0.98 mm by 0.98 mm. For subject 2 (Fig. 7), scans were acquired
on a Philips Healthcare 3T Ingenia using the following protocol: T1
stealth sequence, TR = 6.005 ms, TE = 2.68 ms, flip angle = 8°, slice
thickness = 1 mm, and pixel size = 1 mm by 1 mm.
Intraoperative optical data acquisition
During the superficial vessel protocol, craniotomy and durotomy were
first performed, which exposed the network of vessels on the cerebral
cortical surface. For each vessel measurement, a sterile scale bar was
placed near the vessel and the imaging needle was rolled across the ves-
sel to simulate needle movement during acquisition of the OCT signal.
The needlewas rolled rather than dragged across the vessel to reduce the
risk of inadvertent hemorrhage. An intraoperative photograph was
acquired showing the imaging needle, vessel, and scale bar to enable
later analysis of vessel diameter. The vessel was also identified as either
arterial or venous by the neurosurgeons (H.R. and C.R.P.L.). During
OCT acquisition, our bespoke acquisition and analysis software
displayed the OCT image to the neurosurgeon in real time, overlaid
with measurements of the rate of speckle decorrelation. Areas of high
speckle decorrelationwere color coded (white and yellow) to provide an
intraoperative indication of the presence of blood flow. These measure-
ments were then repeated in negative control locations that showed no
visible sign of vasculature.
An additional deep vessel protocol was performed on three patients
before the superficial vessel protocol. All three patients had grade IV
astrocytomas. A vessel adjacent to the tumor was identified on the pre-
operativeMRI scan.A single burr holewasmade, and the imagingneedle
was manually inserted to the depth of the vessel under stereotactic guid-Ramakonar et al., Sci. Adv. 2018;4 : eaav4992 19 December 2018ance (StealthStation, Medtronic, USA), acquiring OCT A-scans during
the entire insertion. Once we had inserted to the planned depth, the im-
aging needle was rotated to confirmwhether a blood vessel was adjacent
to the needle. Rotation of the imaging needle was necessary, as earlier
work has established that stereotactic guidance alone may lack sufficient
accuracy to identify on which side of the needle the vessel will be located
(13). The OCT scans, shown as insets in Figs. 6 to 8, were acquired once
the needle had been rotated at a depth to image the vessel and then as the
needle was gradually pulled back and removed. TheOCT scans acquired
during initial insertion were of comparable quality.
Analysis of gold standard intraoperative photographs
A high-quality photograph (camera: Nikon D3, 12 megapixels, digital
single-lens reflex) of each superficial vessel was acquired during OCT
imaging, with a sterile scale bar positioned on the brain adjacent to the
vessel. Vessel diameters were measured from the photographs using
ImageJ (49), with the dimensions normalized against the sterile scale
bar to give an absolute measurement in fractions of a millimeter. Spa-
tial resolution of the photographs was approximately 42 mm per pixel.
Statistical analysis
ROC curves were used to measure the accuracy of the OCT in
discriminating vessels from controls. AUC, corresponding 95% CIs,
and P values were generated to quantify the level of discrimination
and the probability that the observed sample AUC is true. Threshold
cutoffs were based onYouden’s index derived from sensitivity and spec-
ificity values of the ROC curves. Fisher’s exact two-sided tests were con-
ducted between vessel type (all vessels and vessels >0.5mm in diameter)
as per gold standard photographic identification of vessels and speckle
decorrelation against threshold values. AMann-WhitneyU test was run
to determine flow difference between controls and vessels. Data were
analyzed using IBM SPSS version 24.0 (Armonk, NY). P values <0.05
were considered statistically significant.SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/4/12/eaav4992/DC1
Fig. S1. MRI scans for deep vessel insertion #1 (corresponding to the OCT scan shown in Fig. 6).
Fig. S2. MRI scans for deep vessel insertion #2 (corresponding to the OCT scan shown in Fig. 7).
Fig. S3. MRI scans for deep vessel insertion #3 (corresponding to the OCT scan shown in Fig. 8).REFERENCES AND NOTES
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